Transitional cell carcinoma in fishing cats (Prionailurus viverrinus): Pathology and expression of cyclooxygenase-1, -2, and p53

Veterinary Pathology

Volumn 43, Issue 5, 2006, Pages 674-681

  Landolfi, J A ^a   Terio, K A ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

COX 1; COX 2; Cyclooxygenase; Fishing cat; Immunohistochemistry; p53; Prionailurus viverranus; Transitional cell carcinoma; Urinary bladder

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLADDER; BLADDER TUMOR; FELIDAE; FEMALE; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; PATHOLOGY; TRANSITIONAL CELL CARCINOMA; ZOO ANIMAL;

ANIMAL DISEASES; ANIMALS; ANIMALS, ZOO; CARCINOMA, TRANSITIONAL CELL; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FELIDAE; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; IMMUNOHISTOCHEMISTRY; MALE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

PRIONAILURUS; PRIONAILURUS VIVERRINUS;

EID: 33748589968     PISSN: 03009858     EISSN: 03009858     Source Type: Journal    
DOI: 10.1354/vp.43-5-674     Document Type: Article

References (23)

1. Bakkar AA, Wallerand H, Radvanyi F, Lahaye JB, Pissard S, Lecerf L, Kouyoumdjian JC, Abbou CC, Pairon JC, Jaurand MC, Thiery JP, Chopin DK, Diez de Medina SG: FGFR3 and TP53 gene mutation define two distinct pathways in urothelial cell carcinoma of the bladder. Cancer Res 63:8108-8112, 2003
2. Beam SL, Rassnick KM, Moore AS, McDonough SP: An immunohistochemical study of cyclooxygenase-2 expression in various feline neoplasms. Vet Pathol 40:496-500, 2003
3. Borzacchiello G, Ambrosio V, Galati P, Perillo A, Roperto F: Cyclooxygenase-1 and -2 expression in urothelial carcinomas of the urinary bladder in cows. Vet Pathol 40:455-459, 2003
4. Brandau S, Böhle A: Bladder cancer: I. Molecular and genetic basis of carcinogenesis. Eur Urol 39:491-497, 2001
5. Brearley MJ, Thatcher C, Cooper JE: Three cases of transitional cell carcinoma in the cat and a review of the literature. Vet Rec 118:91-94, 1986
6. Curtis LR: Fishing Cat International Studbook. Riverbanks Zoological Park and Botanical Garden, Columbia, SC, 2004
7. Dannenberg AJ, Altorki NK, Boyle JO, Dang C, Howe LR, Weksler BB, Subbaramaiah K: Cyclooxygenase 2: a pharmacological target for the prevention of cancer. Lancet Oncol 2:544-551, 2001
8. Dannenberg AJ, Lippman SM, Mann JR, Subbaramaiah K, DuBois RN: Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets of chemoprevention. J Clin Oncol 23(2):254-266, 2005
9. Doré M, Lanthier I, Sirois J: Cyclooxygenase-2 expression in canine mammary tumors. Vet Pathol 40:207-212, 2003
10. Kumar V, Abbas AK, Fausto N, ed.: Robbins and Cotran Pathologic Basis of Disease, 6th ed., pp. 286-292; 1003-1008. Elsevier, Philadelphia, PA, 1999
11. McEntee MF, Cates JM, Neilsen N: Cyclooxygenase-2 expression in spontaneous intestinal neoplasia of domestic dogs. Vet Pathol 39:428-436, 2002
12. Meuten DJ, Everitt J, Inskeep W, Jacobs RM, Peleteiro M, Thompson KG: Histological Classification of Tumors of the Urinary System of Domestic Animals, series 2, vol XI, pp. 26-33. Armed Forces Institute of Pathology, Washington, DC, 2004
13. Mohammed SI, Craig BA, Mutsaers AJ, Glickman NW, Snyder PW, deGortari AE, Schlittler DL, Coffman KT, Bonney PL, Knapp DW: Effects the cyclooxygenase inhibitor, piroxicam, in combination with chemotherapy on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer. Mol Cancer Ther 2:183-188, 2003
14. Mohammed SI, Khan KNM, Sellers RS, Hayek MG, DeNicola DB, Wu L, Bonney PL, Knapp DW: Expression of cyclooxygenase-1 and 2 in naturally occurring canine cancer. Prostaglandins Leukot Essent Fatty Acids 70:479-483, 2004
15. Mohammed SI, Knapp DW, Bostwick DG, Foster RS, Khan KNM, Masferrer JL, Woerner BM, Snyder PW, Koki AT: Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder. Cancer Res 59:5647-5650, 1999
16. Mutsaers AJ, Widmer WR, Knapp DW: Canine transitional cell carcinoma. J Vet Intern Med 17:136-144, 2003
17. Nowak RM, ed.: Walker's Mammals of the World, 6th ed., p. 814. The Johns Hopkins University Press, Baltimore, MD, 1999
18. Orntoft TF, Wolf H: Molecular alterations in bladder cancer. Urol Res 26:223-233, 1998
19. Schwartz PD, Greene RW, Patnaik AK: Urinary bladder tumors in the cat: a review of 27 cases. J Am Anim Hosp Assoc 21:237-245, 1985
20. Slaton JW, Benedict WF, Dinney CPN: p53 in bladder cancer: mechanism of action, prognostic value, and target for therapy. Urology 57:852-859, 2001
21. Sutherland-Smith M, Harvey C, Campbell M, McAloose D, Rideout B, Morris P: Transitional cell carcinoma in four fishing cats (Prionailurus viverrinus). J Zoo Wildl Med 35(3):370-380, 2004
22. Wimberly HC, Lewis RM: Transitional cell carcinoma in the domestic cat. Vet Pathol 16:223-228, 1979
23. Yeniyol CÖ, Süelözgen T, Vardar E, Sural S, Postaci H, Ayder AR: The relationship of mutant p53 accumulation in transitional cell carcinoma of bladder with pathological stage, grade, recurrence and survival. Int Urol Nephrol 33:473-478, 2001